Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Supporting and hindering environments for participation of adolescents diagnosed with autism spectrum disorder: A scoping review.

Krieger B, Piškur B, Schulze C, Jakobs U, Beurskens A, Moser A.

PLoS One. 2018 Aug 29;13(8):e0202071. doi: 10.1371/journal.pone.0202071. eCollection 2018.

2.
3.
4.

Biotransformation of proterguride in the perfused rat liver.

Krause W, Düsterberg B, Jakobs U, Hoyer GA.

Drug Metab Dispos. 1993 Mar-Apr;21(2):203-8.

PMID:
8097686
5.

Pharmacokinetics of nocloprost in human volunteers and its relation to dose.

Tüber U, Brudny-Klöppel M, Jakobs U, Madetzki C, Mahler M.

Eur J Clin Pharmacol. 1993;44(5):497-500.

PMID:
8359191
6.

[Drug substitution and withdrawal in pregnancy. Indication, side effects, acute status, monitoring and results].

Weingart-Jesse B, Stauber M, Hiller K, Jakobs U, Lutz R.

Gynakologe. 1991 Dec;24(6):322-6. German. No abstract available.

PMID:
1773975
8.

Synthesis of a deuterated analogue and development of antibody/GC/MS for the determination of nocloprost in plasma.

Krause W, Jakobs U, Buckenauer R, Biere H.

Prostaglandins. 1990 Sep;40(3):283-96.

PMID:
2247618
9.

Development, validation and practical use of a sensitive and specific radioimmunoassay for the determination of iloprost.

Hildebrand M, Nieuweboer B, Biere H, Klar U, Seemann G, Krause W, Jakobs U.

Eicosanoids. 1990;3(3):165-9.

PMID:
1700724
10.

Development of antibody-mediated extraction followed by GC/MS (antibody/GC/MS) and its application to iloprost determination in plasma.

Krause W, Jakobs U, Schulze PE, Nieuweboer B, Hümpel M.

Prostaglandins Leukot Med. 1985 Feb;17(2):167-82.

PMID:
3885265
12.

Supplemental Content

Loading ...
Support Center